Chronicle Journal: Finance

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Cue Biopharma Inc (NQ: CUE )

13.52 USD +0.46 (+3.56%)
Streaming Delayed Price Updated: 10:41 AM EST, Mar 8, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 495,896
Open 14.55
Bid (Size) 13.51 (1)
Ask (Size) 13.59 (2)
Prev. Close 13.05
Today's Range 13.35 - 14.65
52wk Range 9.300 - 31.69
Shares Outstanding 20,130,766
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Cue Biopharma to Present at the Cowen 41st Annual Health Care Conference
From GlobeNewswire News Releases
Cue Biopharma Enhances Scientific Advisory Board with Appointments of Immunology and Immunotherapy Experts Dr. Abul K. Abbas and Dr. Michael Kalos
From GlobeNewswire News Releases

Performance

YTD
+9.34%
+9.34%
1 Month
-8.87%
-8.87%
3 Month
-0.62%
-0.62%
6 Month
-14.84%
-14.84%
1 Year
-25.78%
-25.78%

More News

Read More
Cue Biopharma to Present at the 7th Annual Immuno-Oncology 360° Conference
From GlobeNewswire News Releases
Cue Biopharma Announces Appointment of Matteo Levisetti, M.D. as Senior Vice President of Clinical Development
From GlobeNewswire News Releases
Cue Biopharma Initiates Patient Dosing in Phase 1 Study of CUE-101 in Combination with KEYTRUDA® (pembrolizumab) as First-line Treatment for HPV+ Recurrent/Metastatic Head and Neck Cancer
From GlobeNewswire News Releases
Cue Biopharma to Present at the Piper Sandler 32nd Annual Healthcare Conference
From GlobeNewswire News Releases
Cue Biopharma Extends Research Collaboration for the Development of Immuno-STAT Biologics for the Treatment of Defined Autoimmune Diseases with Merck
From GlobeNewswire News Releases
Cue Biopharma Reports Third Quarter 2020 Results and CUE-101 Phase 1 Dose Escalation Trial Updates
From GlobeNewswire News Releases
Cue Biopharma to Present at Upcoming Investor Conferences in November 2020
From GlobeNewswire News Releases
Cue Biopharma to Host Business Update Call and Webcast
From GlobeNewswire News Releases
How The Pieces Add Up: LABU Headed For $205
Tags ETFs
From ETF Channel
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

© Copyright 2015, Chronicle Journal, Thunder Bay, ON. Powered by BLOX Content Management System from TownNews.com. [Terms of Use | Privacy Policy]